Stent Graft System
- UID
- IMP/MD/2019/000451_4e1501c99ce27b28129b025c3e7fdcf9_8c512d15b534cc73ecdedce4a8b607f2
- Device class
- Class D
- Brand name
- E-vita Thoracic 3G
- License holder
- Vibgyor Health Care Pvt. Ltd.
- Approving authority
- CDSCO
- Product information
- The E-vita OPEN PLUS Stent Grafts from JOTEC GmbH have been specifically developed for the treatment of aneurysms, dissections and specific lesions of the thoracic aorta. The indications for the use of the E-vita OPEN PLUS Stent Graft from JOTEC GmbH primarily involve acutely life-threatening patient conditions due to: • acute aortic dissections (E-vita Thoracic 3G) extending deep into the descending aorta, • acute aortic dissections (E-vita Thoracic 3G) in combination with Marfan syndrome, • extensive aortic aneurysms of the ascending aorta or ofthe aortic arch extending to the descending aorta (E-vita Thoracic 3G), • complex aortic dissections (E-vita Thoracic 3G) or • chronic extensive aortic dissections
Stent Graft System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2019/000451_4e1501c99ce27b28129b025c3e7fdcf9_8c512d15b534cc73ecdedce4a8b607f2. This device is marketed under the brand name E-vita Thoracic 3G. The license holder is Vibgyor Health Care Pvt. Ltd., and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.